Sep. 27, 2018 / Genomic Medicine / News & Insights
One Gene: Two Distinct Disease Patterns
A new study examining the gene phosphate and tensin homolog (PTEN) calls for both early detection of cancer and awareness of the importance of precision therapy.
Is It Time to Use Pharmacogenomics to Guide Tamoxifen Dosing?
Is it time for us to use pharmacogenomics to find safe and effective doses of tamoxifen for patients — optimizing clinical outcomes with minimal side effects? Dr. Jennifer Hockings discusses.
Dec. 14, 2015 / Genomic Medicine / Innovations
Patterns of DNA Methylation May Differentiate Indolent and Aggressive Prostate Cancers
Differences between indolent and aggressive forms of prostate cancer have been identified based on patterns of DNA methylation according to researchers Lerner Research Institute of the Cleveland Clinic.
Genetics at the Forefront
Charis Eng, MD, PhD, Chair and Director of Cleveland Clinic's Genomic Medicine Institute, shares her views on genetics-related Top 10 Innovations.
Mar. 11, 2015 / Otolaryngology & Dentistry / Best Practices
Paraganglioma Management: How and Why Genomic Medicine Plays an Increasingly Vital Role
A multidisciplinary effort involving Cleveland Clinic's Head & Neck Institute, oncologists and medical geneticists attempts to identify and manage patients with genetic predispositions to paraganglioma.
Feb. 6, 2015 / Cancer / News & Insight
Personalized Cancer Care: A Conversation with Cleveland Clinic's Brian Bolwell, MD (Video 1 of 4)
As genomic analyses reveal increasingly complex information about patients' cancers, Cleveland Clinic Taussig Cancer Institute Chairman Brian Bolwell, MD, says a collaborative, multidisciplinary approach to care becomes even more important.
ConsultQD
A site for physicians and healthcare professionals. Discover Cleveland Clinic's latest research insights, innovations, treatment trends and more.